In this study we have also shown that CHRNA5 RNAi might result in reduced DNA damage response (DDR) based on TCGA and METABRIC tumor data, and GSEA and DAVID functional analyses as well as quantification of total and phosphorylated CHEK1 protein levels. The gene discussed is CHEK1; the disease is neoplasm.